Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.

Abstract:

:Page 806, column 1, line 3: The text, which previously read.

journal_name

Clin Drug Investig

authors

Lyseng-Williamson KA

doi

10.1007/s40261-020-00892-9

subject

Has Abstract

pub_date

2020-03-01 00:00:00

pages

291

issue

3

eissn

1173-2563

issn

1179-1918

pii

10.1007/s40261-020-00892-9

journal_volume

40

pub_type

已发布勘误